Evidence map›Paper›PMID 35956991›Full record

ReviewMolecules (Basel, Switzerland)2022

The Potential of Lamiaceae Herbs for Mitigation of Overweight, Obesity, and Fatty Liver: Studies and Perspectives.

Farah Diab, Hawraa Zbeeb, Francesca Baldini, Piero Portincasa, Mohamad Khalil, Laura Vergani

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Current strategies for nonalcoholic fatty liver disease treatment (Review).International journal of molecular medicine · 2024
    Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Farah DiabDepartment of Earth, Environment and Life Sciences (DISTAV), University of Genova, Corso Europa 26, 16132 Genoa, Italy.ORCID 0000-0002-4488-5547
Hawraa ZbeebDepartment of Earth, Environment and Life Sciences (DISTAV), University of Genova, Corso Europa 26, 16132 Genoa, Italy.ORCID 0000-0002-1451-6441
Francesca BaldiniNanoscopy and NIC@IIT, Istituto Italiano di Tecnologia, 16152 Genoa, Italy.ORCID 0000-0002-6284-436X
Piero PortincasaClinica Medica "A. Murri", Department of Biomedical Sciences and Human Oncology, Medical School, University of Bari "Aldo Moro", 70124 Bari, Italy.ORCID 0000-0001-5359-1471
Mohamad KhalilClinica Medica "A. Murri", Department of Biomedical Sciences and Human Oncology, Medical School, University of Bari "Aldo Moro", 70124 Bari, Italy.ORCID 0000-0002-5943-9531
Laura VerganiDepartment of Earth, Environment and Life Sciences (DISTAV), University of Genova, Corso Europa 26, 16132 Genoa, Italy.ORCID 0000-0002-1268-4724
University of Genoa · ITUniversity of Bari Aldo Moro · ITItalian Institute of Technology · IT

Funding

University of Genoa FRA 2021 and 2022
6 · The paper itself

Abstract

Numerous plants, plant extracts, and plant-derived compounds are being explored for their beneficial effects against overweight and liver diseases. Obesity is associated with the increased prevalence of non-alcoholic fatty liver disease (NAFLD), becoming the most common liver disease in Western countries. Obesity and NAFLD are closely associated with many other metabolic alternations such as insulin resistance, diabetes mellitus, and cardiovascular diseases. Many herbs of the Lamiaceae family are widely employed as food and spices in the Mediterranean area, but also in folk medicine, and their use for the management of metabolic disorders is well documented. Hereby, we summarized the scientific results of the medicinal and nutraceutical potential of plants from the Lamiaceae family for prevention and mitigation of overweight and fatty liver. The evidence indicates that Lamiaceae plants may be a cost-effective source of nutraceuticals and/or phytochemicals to be used in the management of metabolic-related conditions such as obesity and NAFLD. PubMed, Google Scholar, Scopus, and SciFinder were accessed to collect data on traditional medicinal plants, compounds derived from plants, their reported anti-obesity mechanisms, and therapeutic targets.

Indexed as

LamiaceaeNon-alcoholic Fatty Liver DiseasePlants, MedicinalObesityOverweightLamiaceaemedicinal plantsnon-alcoholic fatty liver disease (NAFLD)nutraceuticsobesityphytochemicals

Identifiers

PMID35956991
PMCPMC9370348
OpenAlexW4291017374

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.